Objective: To describe the prevalence of neuropsychiatric (NP) syndromes in
a Finnish population of patients with systemic lupus erythematosus (SLE) a
nd to classify them according to the recently developed American College of
Rheumatology (ACR) nomenclature and case definitions for NPSLE. Methods: C
ross-sectional, population-based study covering an area with 440,000 people
. A total of 58 patients with a definite diagnosis of SLE and aged 16 to 65
years were found in the computerized database of the area hospitals. Of th
ese, 46 (79%) agreed to participate. The diagnosis of various NP syndromes
was based on clinical impression (H.A.) following history, examination, rev
iew of medical records, and neuropsychologic testing. Results: At least one
NP syndrome was identified in 42 patients (91%). The most frequent manifes
tation was cognitive dysfunction (n = 37; 81%), followed by headache (n = 2
5; 54%) and mood disorder (n = 20; 43%). When mild NP syndromes (mild cogni
tive deficit, headache, mild depression, anxiety, electroneuromyography-neg
ative polyneuropathy) were excluded, the prevalence of NPSLE dropped to 46%
. Conclusions: According to the ACR nomenclature, there is a high prevalenc
e of NP manifestations in a population-based sample of patients with SLE. M
ost NP syndromes were classified as minor; if they were excluded, the 46%,
prevalence of NPSLE would be slightly less than estimated in previous studi
es.